Retour
46
97
Fourchette du Jour
6,52 €
6,74 €
Fourchette 52 Semaines
3,73 €
10,32 €
Volume
858 328
Moyenne 50J / 200J
7,85 €
/
7,50 €
Clôture Précédente
6,61 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 6,4 | 0,3 |
| P/B | 7,4 | 3,0 |
| ROE % | 621,9 | 3,7 |
| Net Margin % | 9,3 | 3,8 |
| Rev Growth 5Y % | 9,7 | 10,0 |
| D/E | 6,9 | 0,2 |
Objectif de Cours des Analystes
Hold
11,25 €
+69.9%
Low: 10,00 €
High: 13,00 €
P/E Prévisionnel
11,41
BPA Prévisionnel
0,58 €
Croissance BPA (est.)
+0,0%
CA Est.
2,42B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,76 €
0,75 € – 0,77 €
|
2,84B | 2 |
| FY2028 |
0,69 €
0,61 € – 0,80 €
|
2,71B | 5 |
| FY2027 |
0,62 €
0,55 € – 0,68 €
|
2,56B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-19 | 0,15 € | 0,83 € | +452,2% |
| 2025-11-06 | 0,08 € | 0,15 € | +87,5% |
| 2025-08-07 | 0,04 € | 0,18 € | +350,0% |
| 2025-05-08 | 0,03 € | 0,10 € | +216,8% |
| 2025-03-13 | 0,00 € | 0,05 € | +1178,8% |
| 2024-11-07 | 0,01 € | 0,02 € | +254,0% |
| 2024-08-08 | 0,00 € | 0,01 € | +150,0% |
| 2024-05-09 | -0,05 € | -0,03 € | +40,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 9,73% annually over 5 years — modest growth
ROE of 621,89% indicates high profitability
Debt/Equity of 6,91 — high leverage
Generating 114,79M in free cash flow
P/E of 6,40 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,46%
Croissance
Revenue Growth (5Y)
9,73%
Revenue (1Y)20,19%
Earnings (1Y)N/A
FCF Growth (3Y)163,32%
Qualité
Return on Equity
621,89%
ROIC12,94%
Net Margin9,25%
Op. Margin10,91%
Sécurité
Debt / Equity
6,91
Current Ratio1,32
Interest Coverage1,89
Valorisation
P/E Ratio
6,40
Forward P/E11,56
P/B Ratio7,40
EV/EBITDA9,76
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,19% | Revenue Growth (3Y) | 13,31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,73% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,43B | Net Income (TTM) | 225,03M |
| ROE | 621,89% | ROA | 11,11% |
| Gross Margin | 33,09% | Operating Margin | 10,91% |
| Net Margin | 9,25% | Free Cash Flow (TTM) | 114,79M |
| ROIC | 12,94% | FCF Growth (3Y) | 163,32% |
| Safety | |||
| Debt / Equity | 6,91 | Current Ratio | 1,32 |
| Interest Coverage | 1,89 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 6,40 | Forward P/E | 11,56 |
| P/B Ratio | 7,40 | P/S Ratio | 0,59 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 9,76 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,60 | Fwd Earnings Yield | 8,65% |
| FCF Yield | 7,97% | ||
| Market Cap | 1,44B | Enterprise Value | 2,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,43B | 2,02B | 1,90B | 1,79B | 1,68B |
| Net Income | 225,03M | -10,93M | -134,52M | -662,03M | -117,04M |
| EPS (Diluted) | 1,05 | -0,06 | -0,71 | -3,57 | -0,63 |
| Gross Profit | 805,15M | 635,54M | 595,43M | 553,23M | 542,40M |
| Operating Income | 265,38M | 139,79M | 8,07M | -642,28M | -36,11M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,03B | 1,66B | 1,61B | 1,71B | 2,33B |
| Total Liabilities | 1,83B | 1,79B | 1,74B | 1,72B | 1,70B |
| Shareholders' Equity | 194,46M | -122,09M | -127,44M | -4,18M | 637,95M |
| Total Debt | 1,34B | 1,50B | 1,50B | 1,36B | 1,30B |
| Cash & Equivalents | 193,26M | 84,29M | 43,94M | 19,22M | 30,49M |
| Current Assets | 560,23M | 392,67M | 314,89M | 269,75M | 279,22M |
| Current Liabilities | 424,46M | 402,17M | 354,76M | 326,50M | 344,83M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#206 of 618
#2 of 670
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026